- Home
- DNN vs SUPN Comparison
DNN vs SUPN Comparison
Compare DNN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- SUPN
- Stock Information
- Founded
- DNN 1936
- SUPN 2005
- Country
- DNN Canada
- SUPN United States
- Employees
- DNN N/A
- SUPN N/A
- Industry
- DNN Other Metals and Minerals
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- SUPN Health Care
- Exchange
- DNN Nasdaq
- SUPN Nasdaq
- Market Cap
- DNN 1.3B
- SUPN 1.8B
- IPO Year
- DNN 1997
- SUPN 2012
- Fundamental
- Price
- DNN $1.85
- SUPN $33.96
- Analyst Decision
- DNN Strong Buy
- SUPN Hold
- Analyst Count
- DNN 2
- SUPN 2
- Target Price
- DNN $3.00
- SUPN $36.00
- AVG Volume (30 Days)
- DNN 137.3M
- SUPN 739.8K
- Earning Date
- DNN 08-07-2025
- SUPN 08-05-2025
- Dividend Yield
- DNN N/A
- SUPN N/A
- EPS Growth
- DNN N/A
- SUPN N/A
- EPS
- DNN N/A
- SUPN 1.11
- Revenue
- DNN $3,176,679.00
- SUPN $667,997,000.00
- Revenue This Year
- DNN $288.69
- SUPN N/A
- Revenue Next Year
- DNN $22.40
- SUPN $12.02
- P/E Ratio
- DNN N/A
- SUPN $29.92
- Revenue Growth
- DNN 24.45
- SUPN 11.82
- 52 Week Low
- DNN $1.08
- SUPN $27.05
- 52 Week High
- DNN $2.47
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- DNN 54.90
- SUPN 66.18
- Support Level
- DNN $1.67
- SUPN $32.49
- Resistance Level
- DNN $1.86
- SUPN $33.80
- Average True Range (ATR)
- DNN 0.09
- SUPN 0.91
- MACD
- DNN -0.01
- SUPN 0.23
- Stochastic Oscillator
- DNN 57.14
- SUPN 99.37
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.